In a recent exclusive interview, Fierce Biotech’s Chris Hayden sat down with Alex MacDonald, Vice President of Model-Informed Drug Development at Allucent, to explore the impact of Project Optimus, an ...

Ametris (formerly ActiGraph) has launched its second Digital Endpoint Collaboration Outcome Development (DECODE) working group for the purpose of enhancing drug development for obesity. The ...

TUCSON, Ariz., November 19, 2024 — Critical Path Institute® (C-Path) today announced that its Translational Therapeutics Accelerator (TRxA) program, in partnership with The Leona M. and Harry B.

TUCSON, Ariz., June 18, 2025 — Critical Path Institute’s® (C-Path) Translational Therapeutics Accelerator (TRxA) proudly announced today a $250,000 grant award aimed at developing a novel treatment ...

A new project seeking to transform the drug delivery process and take projects out of “the valley of death” between aspiration and accomplishment is getting help from La Jolla-based medical research ...

Global harmonization of CMC guidelines is a key focus for top pharmaceutical consultants. Variations in regulatory requirements across regions often create inefficiencies in drug development—for ...

Improved understanding of regulatory requirements by academic researchers can accelerate the translation of new medical interventions to the clinic. Here, we highlight the recommendations of the ...

Companies operating in the pharmaceutical and biotech sectors must evaluate a range of critical factors prior to partnering with a contract development and manufacturing organization (CDMO). Selecting ...

When you’re trying to solve a puzzle, having all the pieces isn’t enough. You need a strategy. For example, if you want to complete a jigsaw puzzle, you’ll probably begin by piecing together its edges ...